2021
DOI: 10.1101/2021.08.10.455846
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics

Abstract: The antibiotic linezolid, the first clinically approved member of the oxazolidinone class, inhibits translation of bacterial ribosomes by binding to the peptidyl transferase center. Recent work has demonstrated that linezolid does not inhibit peptide bond formation at all sequences but rather acts in a context-specific manner, namely when alanine occupies the penultimate position of the nascent chain. In this study, we determined that the second-generation oxazolidinone radezolid also induces stalling with ala… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…5B), where they are stabilized in a nonproductive configuration, possibly via direct interactions with a composite surface defined by Sec61 and R-5 of the bound cotransin. This mechanism is reminiscent of nascent chain-selective ribosome inhibitors, which bind to a composite surface defined by the ribosome exit tunnel and specific nascent polypeptide sequences that traverse the exit tunnel [38][39][40] . Cotransin-resistant signal peptides, on the other hand, can apparently displace the bound inhibitor, intercalate between the lateral gate helices, insert into the lipid bilayer, and ultimately promote opening of the lumenal plug domain.…”
Section: Discussionmentioning
confidence: 99%
“…5B), where they are stabilized in a nonproductive configuration, possibly via direct interactions with a composite surface defined by Sec61 and R-5 of the bound cotransin. This mechanism is reminiscent of nascent chain-selective ribosome inhibitors, which bind to a composite surface defined by the ribosome exit tunnel and specific nascent polypeptide sequences that traverse the exit tunnel [38][39][40] . Cotransin-resistant signal peptides, on the other hand, can apparently displace the bound inhibitor, intercalate between the lateral gate helices, insert into the lipid bilayer, and ultimately promote opening of the lumenal plug domain.…”
Section: Discussionmentioning
confidence: 99%